Abstract
There are a number of factors to consider in choosing a muscle relaxant for patients with a phaeochromocytoma. It has been suggested that pancuronium is the muscle relaxant of choice.1-3 This report describes a severe hypertensive response associated with pancuronium in a patient undergoing surgery for the removal of a phaeochromocytoma.
Résumé
On doit tenir compte de plusieurs facteurs lorsqu’il faut administrer un myorésolutif pour l’anesthésie du malade porteur de phéochromocytome. On a préténdu que le pancuronium pouvait être le myorésolutif de choix. Cette observation décrit une crise hypertensive grave associée au pancuronium survenue chez un patient pendant l’exérèse d’un phéochromocytome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Janeczko, G.F., Ivankovich, A.D., Glisson, S.N., Heyman, H.J., El-Etr., A.A. &Albrecht, R.F. Enflurane anaesthesia for surgical removal of pheochromocytoma. Anes. Analg. 56: 62(1977).
Stamenkovic, L.&Spierdijk, J. Anaesthesia in patients with phaeochromocytoma. Anaesthesia31: 941 (1976).
James, M.L. Endocrine disease and anaesthesia. Anaesthesia 25: 232 (1970).
Apgar, V. &Papper, E.M. Pheochromocytoma: anesthetic management during surgical treatment. Arch. Surg.62: 634(1951).
Remine, W.H., Chong, G.C., VanHeerden, J.A., Sheps, S.G. &Harrison, E.G. Current management of pheochromocytoma. Ann. Surg.179: 740 (1974).
Crout, J.R. &Brown, B.R. Anesthetic man- agement of pheochromocytoma: The value of phenoxybenzamine and methoxyflurane. Anesthesiology30: 29 (1969).
Millar, R.A. Pituitary and adrenal glands in relation to anaesthesia.In: General Anaesthesia, 4th ed. Edited by Gray, T.C., Nunn J.F., Utting, J.E. London, Butterworths, 1980, pp. 818–822.
Pratilas, V. &Pratila, M.G. Management of Pheochromocytoma. Anesth. Rev. VI: 44 (1979).
Calvey, T.N. &Wilson, H. Muscle relaxant drugs and their antagonists.In: General Anaesthesia, 4th ed. Edited by Gray, T.C., Nunn, J.F., Utting, J.E. London, Butterworths, 1980, pp. 328.
Domenech, J.S., Garcia, R.C., Rodriguez Sasiain, J.M., Loyola, A.Q. &Oroz, J.S. Pancuronium bromide: an indirect sympathomimetic agent. Brit. J. Anaesth.48: 1143 (1976).
Nana, A., Cardan, E. &Domokos, M. Blood catecholamine changes after pancuronium. Acta anaesth. Scand.17: 83 (1973).
Johns, V.J. &Brunjes, S. Pheochromocytoma. Am. J.Card.9: 120 (1962).
Harrison, T.S., Dagher, F.J., Beck, L. &Bartlett, J.D. Rationale and indications for preoperative adrenergic receptor blockade in pheoehromocytoma. Med. Clin. N. Am.55: 1349 (1969).
Clarke, A.D., Tobias, M.A. &Challen, P.D. The use of neuroeptanalgesia during surgery for pheochromocytoma, Report of two cases. Brit. J. anaesth.44: 1093 (1972).
Whitwam, J.G. &Russell, W.J. The acute cardiovascular changes and adrenergic blockade by droperidol in man. Brit. J Anaesth.43: 581 (1971).
Long, G., Dripps, R.D. &Price, H.L. Measurement of antiarrhythmic potency of drugs in man. Anesthesiology28: 318 (1967).
Sumikawa, K. &Amakata, Y. The pressor effect of droperidol on a patient with pheochromocytoma. Anesthesiology46: 359 (1977).
Bittar, D.A. Innovar-induced hypertensive crises in patients with pheochromocytoma. Anesthesiology50: 366 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, R.M., Hill, A.B. Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma. Canad. Anaesth. Soc. J. 28, 394–396 (1981). https://doi.org/10.1007/BF03007810
Issue Date:
DOI: https://doi.org/10.1007/BF03007810